DiaMedica Therapeutics Inc. (DMAC)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
7. 30
+0.17
+2.3843%
$
400.35M Market Cap
- P/E Ratio
- Div Yield
199,800 Volume
-0.72 Eps
$ 7.13
Previous Close 
Want to track DMAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DiaMedica Therapeutics Inc. (DMAC) Statistics
Valuation metrics
Market Cap 400.35M
Enterprise value 388.69M
Trailing P/E (ttm) -10.28
Forward P/E -
PEG ratio 0.98
Price/Sales (ttm) -
Price/Book (mrq) 8.31
Enterprise Value/Revenue -
Enterprise Value/EBITDA -11.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 199.16K
Average volume (90 days) 195.38K
Price summary
52-Week low 3.65
52-Week high 10.42
Beta -
50-Day moving average 6.47
200-Day moving average 7.27
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 15 Nov 2018
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.66%
Return on equity -0.77%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 9.11%
Book value per share (mrq) 0.88
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
